Rationale and design of a randomized trial to test the safety and non-inferiority of canagliflozin in patients with diabetes with chronic heart failure: the CANDLE trial

BACKGROUND: Because type 2 diabetes mellitus is associated strongly with an increased risk of cardiovascular diseases, the number of patients with diabetes with chronic heart failure is increasing steadily. However, clinical evidence of therapeutic strategies in such patients is still lacking. A rec...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Cardiovasc Diabetol
Główni autorzy: Tanaka, Atsushi, Inoue, Teruo, Kitakaze, Masafumi, Oyama, Jun-ichi, Sata, Masataka, Taguchi, Isao, Shimizu, Wataru, Watada, Hirotaka, Tomiyama, Hirofumi, Ako, Junya, Sakata, Yasushi, Anzai, Toshihisa, Uematsu, Masaaki, Suzuki, Makoto, Eguchi, Kazuo, Yamashina, Akira, Saito, Yoshihiko, Sato, Yasunori, Ueda, Shinichiro, Murohara, Toyoaki, Node, Koichi
Format: Artigo
Język:Inglês
Wydane: BioMed Central 2016
Hasła przedmiotowe:
Study Protocol
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4820875/
https://ncbi.nlm.nih.gov/pubmed/27044332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-016-0381-x
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy